EA007351B1 - Фармацевтическая композиция для чрескожной доставки физиологически активных агентов - Google Patents

Фармацевтическая композиция для чрескожной доставки физиологически активных агентов Download PDF

Info

Publication number
EA007351B1
EA007351B1 EA200500082A EA200500082A EA007351B1 EA 007351 B1 EA007351 B1 EA 007351B1 EA 200500082 A EA200500082 A EA 200500082A EA 200500082 A EA200500082 A EA 200500082A EA 007351 B1 EA007351 B1 EA 007351B1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
agent
composition according
physiologically active
skin
Prior art date
Application number
EA200500082A
Other languages
English (en)
Russian (ru)
Other versions
EA200500082A1 (ru
Inventor
Игорь Гонда
Тимоти Матиас Морган
Нина Франсис Уилкинс
Original Assignee
АКРУКС ДиДиЭс ПиТиУай ЭлТиДи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by АКРУКС ДиДиЭс ПиТиУай ЭлТиДи filed Critical АКРУКС ДиДиЭс ПиТиУай ЭлТиДи
Publication of EA200500082A1 publication Critical patent/EA200500082A1/ru
Publication of EA007351B1 publication Critical patent/EA007351B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EA200500082A 2002-06-25 2003-06-24 Фармацевтическая композиция для чрескожной доставки физиологически активных агентов EA007351B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPS3171A AUPS317102A0 (en) 2002-06-25 2002-06-25 Transdermal aerosol compositions
PCT/AU2003/000784 WO2004000275A1 (en) 2002-06-25 2003-06-24 Transdermal aerosol compositions

Publications (2)

Publication Number Publication Date
EA200500082A1 EA200500082A1 (ru) 2005-06-30
EA007351B1 true EA007351B1 (ru) 2006-10-27

Family

ID=3836730

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200500082A EA007351B1 (ru) 2002-06-25 2003-06-24 Фармацевтическая композиция для чрескожной доставки физиологически активных агентов

Country Status (9)

Country Link
EP (1) EP1534241A1 (pt)
JP (1) JP2005533795A (pt)
KR (1) KR20050071373A (pt)
AU (1) AUPS317102A0 (pt)
BR (1) BR0312004A (pt)
CA (1) CA2490325A1 (pt)
EA (1) EA007351B1 (pt)
NZ (1) NZ537435A (pt)
WO (1) WO2004000275A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ537360A (en) * 2002-06-25 2006-09-29 Acrux Dds Pty Ltd Transdermal delivery rate control using amorphous pharmaceutical compositions
MXPA06005743A (es) * 2003-11-19 2007-04-17 Acrux Dds Pty Ltd Metodo y composicion para el tratamiento o profilaxis de trastornos de amiloidosis.
US20060263421A1 (en) 2005-05-18 2006-11-23 Abeille Pharmaceuticals Inc Transdermal Method and Patch for Nausea
CA2704117C (en) * 2007-11-02 2015-11-17 Acrux Dds Pty Ltd Transdermal delivery system
DK2675453T3 (en) * 2011-02-15 2018-10-29 Elanco Us Inc PROCEDURE FOR COMBATING DOGS WITH DOGS USING A TRANSDERMAL SOLUTION OF FENTANYL
PL2675454T3 (pl) * 2011-02-15 2020-10-05 Audevard Sposoby kontrolowania bólu u koniowatych przy zastosowaniu przezskórnego roztworu fentanylu
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
WO2020212952A1 (en) 2019-04-17 2020-10-22 Compass Pathfinder Limited Treatment of depression and other various disorders with psilocybin

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082866A (en) * 1988-06-01 1992-01-21 Odontex, Inc. Biodegradable absorption enhancers
WO1997029735A1 (en) * 1996-02-19 1997-08-21 Monash University Dermal penetration enhancers and drug delivery systems involving same
US6004969A (en) * 1996-04-15 1999-12-21 National Science Council Transdermal delivery of buprenorphine preparations
WO2000045795A2 (en) * 1999-02-05 2000-08-10 Cipla Limited Topical sprays comprising a film forming composition
WO2002017923A1 (en) * 2000-08-29 2002-03-07 Ranbaxy Laboratories Limited Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082866A (en) * 1988-06-01 1992-01-21 Odontex, Inc. Biodegradable absorption enhancers
WO1997029735A1 (en) * 1996-02-19 1997-08-21 Monash University Dermal penetration enhancers and drug delivery systems involving same
US6004969A (en) * 1996-04-15 1999-12-21 National Science Council Transdermal delivery of buprenorphine preparations
WO2000045795A2 (en) * 1999-02-05 2000-08-10 Cipla Limited Topical sprays comprising a film forming composition
WO2002017923A1 (en) * 2000-08-29 2002-03-07 Ranbaxy Laboratories Limited Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MORGAN T.M. ET AL., Transdermal Delivery of Estradiol in Postmenopausal Woman with a Novel Topical Aerosol, Journal of Pharmaceutical Sciences, October 1998, Vol. 87, No. 10, 1226-1228. *
MORGAN T.M. ET AL., Transdermal Delivery of Sex Hormones in Swine with a Novel Topical Aerosol, Journal of Pharmaceutical Sciences, October 1998, Vol. 87, No.10, 1219-1225. *

Also Published As

Publication number Publication date
AUPS317102A0 (en) 2002-07-18
EP1534241A1 (en) 2005-06-01
KR20050071373A (ko) 2005-07-07
EA200500082A1 (ru) 2005-06-30
WO2004000275A1 (en) 2003-12-31
BR0312004A (pt) 2005-03-29
NZ537435A (en) 2006-02-24
CA2490325A1 (en) 2003-12-31
JP2005533795A (ja) 2005-11-10

Similar Documents

Publication Publication Date Title
US20050186141A1 (en) Transdermal aerosol compositions
JP5568108B2 (ja) 非晶質医薬組成物を用いる経皮送達速度調節
US7387788B1 (en) Pharmaceutical compositions of nicotine and methods of use thereof
US20070280972A1 (en) Adhesive solid gel-forming formulations for dermal drug delivery
US20090042950A1 (en) Transdermal topical composition and its uses
US20070196458A1 (en) Compositions and methods for dermally treating neuropathic pain
JP2000504697A (ja) 皮膚浸透増強剤及びそれを含む薬剤デリバリーシステム
JPS60152413A (ja) メントールにより経皮性薬剤放出の強化を行なつた局所用組成物
KR20050024307A (ko) 경피 흡수 제제
EA007351B1 (ru) Фармацевтическая композиция для чрескожной доставки физиологически активных агентов
JP5667052B2 (ja) ダナゾールを含む経真皮医薬組成物
WO2008012071A2 (en) Pharmaceutical compositions of nicotine and methods of use thereof
JP2007509122A (ja) Ｖｐ／ｖａ共重合体及び非水性ビヒクルを含有する、経皮的医薬スプレー製剤
CA2433101A1 (en) Method of treatment of a female suffering from androgen insufficiency
AU2003238543B2 (en) Transdermal aerosol compositions
JPH09509676A (ja) ツメを使用する系統的な薬品配送システム
JPH06184000A (ja) （−）−イソプレゴールからなる経皮吸収促進剤

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU